Caricamento...
Antibody–Drug Conjugates for Cancer Therapy
Antibody–drug conjugates (ADCs) take advantage of the specificity of a monoclonal antibody to deliver a linked cytotoxic agent directly into a tumour cell. The development of these compounds provides exciting opportunities for improvements in patient care. Here, we review the key issues impacting on...
Salvato in:
| Pubblicato in: | Biomedicines |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344263/ https://ncbi.nlm.nih.gov/pubmed/28536381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines4030014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|